These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 22580623)

  • 1. Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma.
    Due AK; Vogelius IR; Aznar MC; Bentzen SM; Berthelsen AK; Korreman SS; Kristensen CA; Specht L
    Strahlenther Onkol; 2012 Aug; 188(8):671-6. PubMed ID: 22580623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake.
    Due AK; Vogelius IR; Aznar MC; Bentzen SM; Berthelsen AK; Korreman SS; Loft A; Kristensen CA; Specht L
    Radiother Oncol; 2014 Jun; 111(3):360-5. PubMed ID: 24993331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer.
    Chen AM; Farwell DG; Luu Q; Chen LM; Vijayakumar S; Purdy JA
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1423-9. PubMed ID: 20656416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of Failure in Patients With Head and Neck Squamous Cell Carcinomas of Unknown Primary Treated With Chemoradiotherapy.
    Dhouib F; Bertaut A; Maingon P; Siala W; Daoud J; Aubignac L; Lestrade L; Crehange G; Vulquin N
    Technol Cancer Res Treat; 2020; 19():1533033820905826. PubMed ID: 32484037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodologies for localizing loco-regional hypopharyngeal carcinoma recurrences in relation to FDG-PET positive and clinical radiation therapy target volumes.
    Due AK; Korreman S; Bentzen SM; Tomé W; Bender E; Aznar M; Vogelius I; Berthelsen AK; Kristensen CA; Specht L
    Acta Oncol; 2010 Oct; 49(7):984-90. PubMed ID: 20831486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study.
    Cvek J; Kubes J; Skacelikova E; Otahal B; Kominek P; Halamka M; Feltl D
    Strahlenther Onkol; 2012 Aug; 188(8):666-70. PubMed ID: 22648405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geometric analysis of loco-regional recurrences in relation to pre-treatment hypoxia in patients with head and neck cancer.
    Boeke S; Thorwarth D; Mönnich D; Pfannenberg C; Reischl G; La Fougère C; Nikolaou K; Mauz PS; Paulsen F; Zips D; Welz S
    Acta Oncol; 2017 Nov; 56(11):1571-1576. PubMed ID: 28891398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer.
    Lambrecht M; Nevens D; Nuyts S
    Strahlenther Onkol; 2013 Mar; 189(3):223-9. PubMed ID: 23319256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is image registration of fluorodeoxyglucose-positron emission tomography/computed tomography for head-and-neck cancer treatment planning necessary?
    Fried D; Lawrence M; Khandani AH; Rosenman J; Cullip T; Chera BS
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):748-54. PubMed ID: 22414285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Planned postradiotherapy neck dissection in patients with advanced head and neck cancer.
    Boyd TS; Harari PM; Tannehill SP; Voytovich MC; Hartig GK; Ford CN; Foote RL; Campbell BH; Schultz CJ
    Head Neck; 1998 Mar; 20(2):132-7. PubMed ID: 9484944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
    Hideghéty K; Cserháti A; Besenyi Z; Zag L; Gaál S; Együd Z; Mózes P; Szántó E; Csenki M; Rusz O; Varga Z; Dobi Á; Maráz A; Pávics L; Lengyel Z
    Magy Onkol; 2015 Jun; 59(2):103-10. PubMed ID: 26035157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines.
    Grégoire V; Evans M; Le QT; Bourhis J; Budach V; Chen A; Eisbruch A; Feng M; Giralt J; Gupta T; Hamoir M; Helito JK; Hu C; Hunter K; Johansen J; Kaanders J; Laskar SG; Lee A; Maingon P; Mäkitie A; Micciche' F; Nicolai P; O'Sullivan B; Poitevin A; Porceddu S; Składowski K; Tribius S; Waldron J; Wee J; Yao M; Yom SS; Zimmermann F; Grau C
    Radiother Oncol; 2018 Jan; 126(1):3-24. PubMed ID: 29180076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative irradiation in cancer of the head and neck.
    Moore C; Mullins F; Scott RM
    Am J Surg; 1972 Oct; 124(4):555-8. PubMed ID: 4627680
    [No Abstract]   [Full Text] [Related]  

  • 15. Success of salvage treatment: a critical appraisal of salvage rates for different subsites of HNSCC.
    Matoscevic K; Graf N; Pezier TF; Huber GF
    Otolaryngol Head Neck Surg; 2014 Sep; 151(3):454-61. PubMed ID: 24894422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of locoregional failure following post-operative intensity-modulated radiotherapy to oral cavity cancer: quantitative spatial and dosimetric analysis using a deformable image registration workflow.
    Mohamed ASR; Wong AJ; Fuller CD; Kamal M; Gunn GB; Phan J; Morrison WH; Beadle BM; Skinner H; Lai SY; Quinlan-Davidson SR; Belal AM; El-Gowily AG; Frank SJ; Rosenthal DI; Garden AS
    Radiat Oncol; 2017 Aug; 12(1):129. PubMed ID: 28806994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of FDG-PET on primary nodal target volume definition for head and neck carcinomas.
    van Egmond SL; Piscaer V; Janssen LM; Stegeman I; Hobbelink MG; Grolman W; Terhaard CH
    Acta Oncol; 2016; 55(9-10):1099-1106. PubMed ID: 27219720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of failure after intensity-modulated radiotherapy in head and neck squamous cell carcinoma using compartmental clinical target volume delineation.
    Bayman E; Prestwich RJ; Speight R; Aspin L; Garratt L; Wilson S; Dyker KE; Sen M
    Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):636-42. PubMed ID: 24928558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.
    Dirix P; Nuyts S
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1373-80. PubMed ID: 20362402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment and topographic characterization of locoregional recurrences in head and neck tumours.
    Ferreira BC; Marques RV; Khouri L; Santos T; Sá-Couto P; do Carmo Lopes M
    Radiat Oncol; 2015 Feb; 10():41. PubMed ID: 25889988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.